Gastroenterology
Volume 137, Issue 6 , Pages 2146-2157, December 2009

Differential Importance of Glucose-Dependent Insulinotropic Polypeptide vs Glucagon-Like Peptide 1 Receptor Signaling for Beta Cell Survival in Mice

  • Adriano Maida

      Affiliations

    • Department of Medicine, Samuel Lunenfeld Research Institute, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada
    • ,
  • Tanya Hansotia

      Affiliations

    • Department of Medicine, Samuel Lunenfeld Research Institute, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada
    • ,
  • Christine Longuet

      Affiliations

    • Department of Medicine, Samuel Lunenfeld Research Institute, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada
    • ,
  • Yutaka Seino

      Affiliations

    • Kyoto University Graduate School of Medicine, Kyoto, Japan
    • ,
  • Daniel J. Drucker

      Affiliations

    • Department of Medicine, Samuel Lunenfeld Research Institute, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada
    • Corresponding Author InformationReprint requests Address requests for reprints to: Daniel J. Drucker, MD, Mount Sinai Hospital, Samuel Lunenfeld Research Institute, 60 Murray Street, Mailbox 39, Toronto, Ontario, Canada M5T 3L9. fax: (416) 361-2669

Received 18 June 2009; accepted 2 September 2009. published online 22 September 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 View this article's video abstract at www.gastrojournal.org.

 Conflicts of interest The authors disclose the following: Dr Drucker has served as an advisor or consultant within the past 12 months to Amylin Pharmaceuticals, Arena Pharmaceuticals Inc, Arisaph Pharmaceuticals Inc, Eli Lilly and Company, GlaxoSmithKline, Glenmark Pharmaceuticals, Hoffman-LaRoche Inc, Isis Pharmaceuticals Inc, Merck Research Laboratories, Metabolex Inc, Novartis Pharmaceuticals, Novo Nordisk Inc, Phenomix Inc, and Transition Pharmaceuticals Inc. Neither Dr Drucker nor his family members hold stock directly or indirectly in any of these companies. The remaining authors disclose no conflicts.

 Funding A.M. was supported by funding from a Canadian Diabetes Association Doctoral Research Award and a Canadian Institutes of Health Research graduate scholarship. These studies were supported in part by a grant from the Juvenile Diabetes Research Foundation (JDRF #1-2006-796) and from the Canadian Institutes of Health Research MOP 82700. D.J.D. was supported in part by the Canada Research Chairs Program.

PII: S0016-5085(09)01569-8

doi:10.1053/j.gastro.2009.09.004

Refers to article:

  • The Incretins and β-Cell Health: Contrasting Glucose-Dependent Insulinotropic Polypeptide and Glucagon-Like Peptide-1 as a Path to Understand Islet Function in Diabetes , 30 October 2009

    Lene Jessen, David D'Alessio
    Gastroenterology December 2009 (Vol. 137, Issue 6, Pages 1891-1894)

Gastroenterology
Volume 137, Issue 6 , Pages 2146-2157, December 2009

Article Tools

* Image Usage & Resolution